Conference Reports for NATAP

62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back

Peginterferon alfa-2a monotherapy as a strategy for achieving sustained response in patientsswitched from long-term nucleos(t)ide analog therapy: the results of 1 year follow up       Reported by Jules Levin AASLD Nov 5-8 2011 SF   Truong Ba Trung and Pham Hoang Phiet Hepatology Division, Ho Chi Minh City University Medical Center, Ho Chi Minh City, Vietnam